Will GLP-1 Agonists Weaken the Links between Obesity and Cancer?
Sign Up to like & getrecommendations! Published in 2025 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-25-0991
Abstract: Glucagon-like peptide 1 receptor agonists hold great promise to reverse some cancer risk in people living with obesity, and emerging clinical trials support this so far. However, some preclinical work and caveats from human studies… read more here.
Keywords: cancer; obesity; weaken links; links obesity ... See more keywords